VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,455 | -10.6% | 500 | 0.0% | 0.01% | -7.1% |
| Q2 2023 | $15,055 | -6.9% | 500 | 0.0% | 0.01% | -6.7% |
| Q1 2023 | $16,175 | +12.9% | 500 | 0.0% | 0.02% | +7.1% |
| Q4 2022 | $14,330 | -93.3% | 500 | -94.3% | 0.01% | -93.1% |
| Q3 2022 | $213,000 | -23.9% | 8,820 | -13.7% | 0.20% | -28.5% |
| Q2 2022 | $280,000 | -28.6% | 10,217 | 0.0% | 0.28% | -20.2% |
| Q1 2022 | $392,000 | +125.3% | 10,217 | +87.6% | 0.36% | +132.7% |
| Q4 2021 | $174,000 | +8.1% | 5,447 | 0.0% | 0.15% | +7.7% |
| Q3 2021 | $161,000 | -13.0% | 5,447 | 0.0% | 0.14% | -12.3% |
| Q2 2021 | $185,000 | – | 5,447 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |